Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo
β Scribed by Qingfen Li; Li Li; Wenfang Shi; Xiaodan Jiang; Yong Xu; Feili Gong; Muxiang Zhou; Carl K. Edwards; Zhuoya Li
- Book ID
- 105967074
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 425 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The potential mechanisms of interferon (1FN)-gamma and tumor necrosis factor (TNF)-alpha action on tumor cells have been investigated in a model of mouse fibroblasts transformed by distinct retroviral vectors carrying the v-mos, c-myc, and v-Ha-ras oncogene, respectively. Treatment with both cytokin
Background: Inhibitors of tumor necrosis factor β£ (TNFβ£) have demonstrated significant efficacy in chronic inflammatory diseases, including Crohn's disease (CD). To further elucidate the mechanisms of action of these agents, we compared the anti-TNFβ£ agents certolizumab pegol, infliximab, adalimumab